At baseline serum NfL levels were significantly higher in patients with progressive MS (PMS), constituting both primary progressive MS (PPMS) and secondary progressive MS (SPMS) subjects, compared to HCs, after adjustment for age and sex. The gene discussed is NEFL; the disease is secondary progressive multiple sclerosis.